TY  - JOUR 
AU  - Martín Izquierdo, Marta
AU  - Abáigar Alvarado, María
AU  - Hernández-Sánchez, Jesús M
AU  - Tamborero, David
AU  - López-Cadenas, Félix
AU  - Ramos, Fernando
AU  - Lumbreras Gonzalez,  Eva
AU  - Madinaveitia-Ochoa, Andrés
AU  - Megido, Marta
AU  - Labrador, Jorge
AU  - Sánchez-Real, Javier
AU  - Olivier, Carmen
AU  - Dávila, Julio
AU  - Aguilar, Carlos
AU  - Rodríguez, Juan N
AU  - Martín-Nuñez, Guillermo
AU  - Santos-Mínguez, Sandra
AU  - Miguel-García, Cristina
AU  - Benito Sánchez, Rocío
AU  - Díez Campelo, María
AU  - Hernández Rivas, Jesús María
PY  - 2021
SN  - 0390-6078
UR  - http://hdl.handle.net/10366/171292
AB  - [EN]Myelodysplastic syndromes (MDS) are hematological disorders at high risk of progression to secondary acute myeloid leukemia (sAML). However, the mutational dynamics and clonal evolution underlying disease progression are poorly understood at...
LA  - eng
KW  - Leukemia, Myeloid, Acute
KW  - Myelodysplastic Syndromes
KW  - Neoplasms, Second Primary
KW  - Cell Cycle Proteins
KW  - Chromosomal Proteins, Non-Histone
KW  - Humans
KW  - Mutation
KW  - Cohesins
KW  - Mutation
KW  - Leukemia
KW  - Humans
KW  - Myelodysplastic Syndromes
KW  - Neoplasms
KW  - Cell Cycle Proteins
TI  - Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia.
DO  - 10.3324/haematol.2020.248807
T2  - Haematologica
VL  - 106
M2  - 2215
ER  -